Aa
AbbVie on the way
Below is an exercpt from a Fierce BioTec News Letter dated this date. i thought it was interesting.
"....The European Medicines Agency has recommended approval for AbbVie's three-agent combination, which, like Gilead's competing Harvoni, uses a cocktail of antivirals to halt viral replication and cure more than 90% of hep C patients. The EMA generally approves medicines about three months after such a recommendation, putting AbbVie on track for an early 2015 launch in Europe.
Once approved, AbbVie's drug would be marketed in two parts: once-a-day Viekirax, which combines the NS5A inhibitor ombitasvir with a fixed-dose combo of paritaprevir and ritonavir that blocks NS3/4A; and twice-daily Exviera, which targets NSB5. Each targeted protein is essential to the spread of hep C, and, in pivotal trials on thousands of patients, AbbVie's multi-pill combination has eradicated the virus in patients with all genotypes without the need for painful interferon injections....'
I can't find the address stuff on my new IPad yet, but if you type 'Fierce BioTec Free Newsletter' it should take you to the site. You might have to sign in, but it does not cost anything and is easy to do. It is a financial take on the big Pharmas, but what the articles say about the meds are clear, easy to understand, and as far as I have seen, correct to the information up to that date.
"....The European Medicines Agency has recommended approval for AbbVie's three-agent combination, which, like Gilead's competing Harvoni, uses a cocktail of antivirals to halt viral replication and cure more than 90% of hep C patients. The EMA generally approves medicines about three months after such a recommendation, putting AbbVie on track for an early 2015 launch in Europe.
Once approved, AbbVie's drug would be marketed in two parts: once-a-day Viekirax, which combines the NS5A inhibitor ombitasvir with a fixed-dose combo of paritaprevir and ritonavir that blocks NS3/4A; and twice-daily Exviera, which targets NSB5. Each targeted protein is essential to the spread of hep C, and, in pivotal trials on thousands of patients, AbbVie's multi-pill combination has eradicated the virus in patients with all genotypes without the need for painful interferon injections....'
I can't find the address stuff on my new IPad yet, but if you type 'Fierce BioTec Free Newsletter' it should take you to the site. You might have to sign in, but it does not cost anything and is easy to do. It is a financial take on the big Pharmas, but what the articles say about the meds are clear, easy to understand, and as far as I have seen, correct to the information up to that date.
This is a great AbbVie site.
HepC.com
Seems like a gear up for January release.
HepC.com
Seems like a gear up for January release.
Wonderful news. For all Genotypes. This is da bomb. Is this the one that comes out Jan 1?
Have an Answer?
You are reading content posted in the Hepatitis C Community
Learn about this treatable virus.
Getting tested for this viral infection.
3 key steps to getting on treatment.
4 steps to getting on therapy.
What you need to know about Hep C drugs.
How the drugs might affect you.
These tips may up your chances of a cure.
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
